Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors - Stock Market -BoardProspects

Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors

Stock Market Jul 29 2016 BoardMoves

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Yahoo co-founder David Filo nominated for company's new board member also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- UniFirst Named a Winning Company by 2020 Women on Boards also published in Stock Market
- Intel CEO to retire as chipmaker struggles with mobile also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Quotes
1. We are pleased that Sarah has agreed to join Valeant's board.
Topics Mentioned